S

Sarepta Therapeutics
D

SRPT

118.040
USD
1.07
(0.91%)
مغلق
حجم التداول
28,628
الربح لكل سهم
12
العائد الربحي
-
P/E
77
حجم السوق
11,275,139,486
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    I
    IONS
    -0.820
    (-2.54%)
    31.440 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    R
    RGLS
    -0.04000
    (-3.13%)
    1.24000 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.